The share price is primarily important because of
Post# of 147848
I'm expecting a bounce back in the general market and small caps, though how sustainable that will be if it happens is yet to be seen, but Cytodyn must raise money to operate and I'm pretty sure that there are still monthly Fife payments to be converted. A depressed share price obviously degrades the effectiveness of the 200 million new shares to some extent.
Hopefully we get a catalyst with a real impact but until then the share price is very material to leronlimab's progress.